SERUM VANCOMYCIN LEVEL IS THE PREPONDERANT PREDICTOR OF ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS TREATED WITH CONTINUOUS VANCOMYCIN INFUSION

被引：0
|
作者：
Snapen, H. [1 ]
Diltoer, M. [1 ]
van Doom, K. Janssen [2 ]
Verbrugghe, W. [2 ]
Jacobs, R. [1 ]
Dobbeleir, N. [1 ]
Honore, P. M. [1 ]
Jorens, P. G. [2 ]
机构：
[1] Vrije Univ, Univ Hosp, Brussels, Belgium
[2] Univ Antwerp, Univ Antwerp Hosp, Edegem, Belgium
来源：
INTENSIVE CARE MEDICINE | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1044
引用
收藏
页码：S266 / S266
页数：1
相关论文
共 50 条
  • [31] Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens
    Roberts, Jason A.
    Taccone, Fabio Silvio
    Udy, Andrew A.
    Vincent, Jean-Louis
    Jacobs, Frederique
    Lipman, Jeffrey
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2704 - 2709
  • [32] Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients
    Herbert D Spapen
    Karin Janssen van Doorn
    Marc Diltoer
    Walter Verbrugghe
    Rita Jacobs
    Nadia Dobbeleir
    Patrick M Honoré
    Philippe G Jorens
    Annals of Intensive Care, 1
  • [33] Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients
    Spapen, Herbert D.
    van Doorn, Karin Janssen
    Diltoer, Marc
    Verbrugghe, Walter
    Jacobs, Rita
    Dobbeleir, Nadia
    Honore, Patrick M.
    Jorens, Philippe G.
    ANNALS OF INTENSIVE CARE, 2011, 1
  • [34] Continuous infusion of vancomycin in critically ill children: do we achieve the target?
    Genuini, M.
    Oualha, M.
    Bouazza, N.
    Moulin, F.
    Treluyer, J. M.
    Lesage, F.
    Renolleau, S.
    Benaboud, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 28 - 28
  • [35] Continuous infusion of vancomycin in critically ill children: do we achieve the target?
    Combret, S.
    Aimene, N.
    Bourneau-Martin, D.
    Bondon-Guitton, E.
    Dautriche, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 55 - 56
  • [36] Continuous infusion of vancomycin in critically ill children: do we achieve the target?
    Genuini, M.
    Oualha, M.
    Bouazza, N.
    Moulin, F.
    Treluyer, J. M.
    Lesage, F.
    Renolleau, S.
    Benaboud, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 55 - 55
  • [37] The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin-Tazobactam or Cefepime
    Molina, Kyle C.
    Barletta, Jeffrey F.
    Hall, Scott T.
    Yazdani, Cyrus
    Huang, Vanthida
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (12) : 1434 - 1438
  • [38] Serum Vancomycin Levels Resulting From Continuous or Intermittent Infusion in Critically Ill Burn Patients With or Without Continuous Renal Replacement Therapy
    Akers, Kevin S.
    Cota, Jason M.
    Chung, Kevin K.
    Renz, Evan M.
    Mende, Katrin
    Murray, Clinton K.
    JOURNAL OF BURN CARE & RESEARCH, 2012, 33 (06): : E254 - E262
  • [39] Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin
    Schreier, Diana J.
    Kashani, Kianoush B.
    Sakhuja, Ankit
    Mara, Kristin C.
    Tootooni, Mohammad S.
    Personett, Heather A.
    Nelson, Sarah
    Rule, Andrew D.
    Steckelberg, James M.
    Tande, Aaron J.
    Barreto, Erin F.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (09) : 1456 - 1462
  • [40] Association between trough serum vancomycin concentration and vancomycin-associated acute kidney injury and 30-day mortality in critically ill elderly adults
    Chen, Jialong
    Lin, Jing
    Weng, Jianzhen
    Ju, Yang
    Li, Yanming
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
12345